King Luther Capital Management Corp Grows Position in HealthEquity, Inc. (NASDAQ:HQY)

King Luther Capital Management Corp lifted its holdings in shares of HealthEquity, Inc. (NASDAQ:HQYFree Report) by 9.5% in the fourth quarter, HoldingsChannel.com reports. The firm owned 50,190 shares of the company’s stock after acquiring an additional 4,343 shares during the quarter. King Luther Capital Management Corp’s holdings in HealthEquity were worth $4,816,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of HQY. Arcadia Investment Management Corp MI purchased a new position in HealthEquity during the 4th quarter valued at about $26,000. Smartleaf Asset Management LLC boosted its stake in shares of HealthEquity by 34.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock valued at $37,000 after buying an additional 98 shares during the period. Proficio Capital Partners LLC purchased a new position in shares of HealthEquity in the 4th quarter valued at about $39,000. UMB Bank n.a. boosted its stake in shares of HealthEquity by 65.6% in the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock valued at $40,000 after buying an additional 164 shares during the period. Finally, Lindbrook Capital LLC boosted its stake in shares of HealthEquity by 27.6% in the 4th quarter. Lindbrook Capital LLC now owns 750 shares of the company’s stock valued at $72,000 after buying an additional 162 shares during the period. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

HealthEquity Trading Up 0.0 %

Shares of HQY stock opened at $95.78 on Thursday. The business’s 50 day moving average is $105.75 and its two-hundred day moving average is $94.93. HealthEquity, Inc. has a twelve month low of $65.01 and a twelve month high of $115.59. The company has a market capitalization of $8.30 billion, a P/E ratio of 87.87, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51.

HealthEquity (NASDAQ:HQYGet Free Report) last announced its earnings results on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period in the previous year, the company earned $0.40 earnings per share. Equities analysts forecast that HealthEquity, Inc. will post 2.32 EPS for the current year.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on HQY shares. JMP Securities lifted their price objective on HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research note on Tuesday, December 10th. The Goldman Sachs Group started coverage on HealthEquity in a research report on Friday, November 15th. They set a “neutral” rating and a $108.00 target price on the stock. Wells Fargo & Company raised their target price on HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 26th. Barrington Research raised their target price on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research report on Monday, December 2nd. Finally, Mizuho initiated coverage on HealthEquity in a research report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 target price on the stock. One investment analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $113.54.

Get Our Latest Research Report on HQY

Insider Activity at HealthEquity

In related news, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the sale, the director now directly owns 78,219 shares in the company, valued at $8,704,992.51. The trade was a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 2.20% of the company’s stock.

HealthEquity Profile

(Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Read More

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQYFree Report).

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.